Top Markets
#1 DogBull DogBull +107.65%
#2 MarsCoin MarsCoin +71.27%
#3 ADO Protocol ADO Protocol +51.79%
#4 Siacoin Siacoin +42.08%
#5 Ontology Gas Ontology Gas +22.87%
#6 The Bitcoin Bull The Bitcoin Bull +16.60%
#7 Apertum Apertum +14.97%
#8 Nockchain Nockchain +12.43%
#9 Useless Coin Useless Coin +12.33%
#10 UnifAI Network UnifAI Network +12.04%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Australian Clinical Labs Limited Australian Clinical Labs Limited

Australian Clinical Labs Limited

ACL
Rank in Stocks #15162
Australian Clinical Labs Limited operates across Australia, delivering a... Australian Clinical Labs Limited operates across Australia, delivering a diverse range of diagnostic pathology services. The company's extensive portfolio encompasses standard examinations alongside advanced molecular genetics, including Harmony NIPT and initial trimester screenings, as well as genetic carrier screening. Furthermore, it provides detailed analyses in chemical, tissue (histopathology), and cellular (cytopathology) pathology; specialized tests for hematology, allergies, and immunology; and comprehensive serology and microbiology services. ACL also performs infectious molecular testing, cardiac diagnostic assessments, functional pathology, veterinary pathology, and commercial drug and alcohol screening. These essential services are supplied to both private and public hospitals throughout the nation. The company was founded in 2020 and maintains its primary operational base in Clayton, Australia.
Share Price
$1.98
Market Cap
$368.99M
Change (1 day)
0.90%
Change (1 year)
11.38%
Country
AU
Trade Australian Clinical Labs Limited (ACL)

Category

Healthcare
P/B ratio for Australian Clinical Labs Limited (ACL)
P/B ratio as of 2026 TTM: 0
According to Australian Clinical Labs Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Australian Clinical Labs Limited from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 4.346 -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 2.8646 -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 25.3254 -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 27.6506 -
US